Literature DB >> 28596245

Computerised cognitive-behavioural therapy for adults with intellectual disability: randomised controlled trial.

Patricia Cooney1, Catherine Jackman2, David Coyle2, Gary O'Reilly2.   

Abstract

BackgroundDespite the evidence base for computer-assisted cognitive-behavioural therapy (CBT) in the general population, it has not yet been adapted for use with adults who have an intellectual disability.AimsTo evaluate the utility of a CBT computer game for adults who have an intellectual disability.MethodA 2 × 3 (group × time) randomised controlled trial design was used. Fifty-two adults with mild to moderate intellectual disability and anxiety or depression were randomly allocated to two groups: computerised CBT (cCBT) or psychiatric treatment as usual (TAU), and assessed at pre-treatment, post-treatment and 3-month follow-up. Forty-nine participants were included in the final analysis.ResultsA significant group × time interaction was observed on the primary outcome measure of anxiety (Glasgow Anxiety Scale for people with an Intellectual Disability), favouring cCBT over TAU, but not on the primary outcome measure of depression (Glasgow Depression Scale for people with a Learning Disability). A medium effect size for anxiety symptoms was observed at post-treatment and a large effect size was observed after follow-up. Reliability of Change Indices indicated that the intervention produced clinically significant change in the cCBT group in comparison with TAU.ConclusionsAs the first application of cCBT for adults with intellectual disability, this intervention appears to be a useful treatment option to reduce anxiety symptoms in this population. © The Royal College of Psychiatrists 2017.

Entities:  

Mesh:

Year:  2017        PMID: 28596245     DOI: 10.1192/bjp.bp.117.198630

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  7 in total

1.  Using Computer Games to Support Mental Health Interventions: Naturalistic Deployment Study.

Authors:  Hidde van der Meulen; Darragh McCashin; Gary O'Reilly; David Coyle
Journal:  JMIR Ment Health       Date:  2019-05-09

Review 2.  eHealth in the support of people with mild intellectual disability in daily life: A systematic review.

Authors:  Cathelijn E M Oudshoorn; Noud Frielink; Sara L P Nijs; Petri J C M Embregts
Journal:  J Appl Res Intellect Disabil       Date:  2020-06-23

Review 3.  Telemedicine Treatment and Care for Patients with Intellectual Disability.

Authors:  Krzysztof Krysta; Monika Romańczyk; Albert Diefenbacher; Marek Krzystanek
Journal:  Int J Environ Res Public Health       Date:  2021-02-11       Impact factor: 3.390

4.  Pesky gNATs for children experiencing low mood and anxiety - A pragmatic randomised controlled trial of technology-assisted CBT in primary care.

Authors:  Darragh McCashin; David Coyle; Gary O'Reilly
Journal:  Internet Interv       Date:  2021-12-27

Review 5.  The Effectiveness of Serious Games for Alleviating Depression: Systematic Review and Meta-analysis.

Authors:  Alaa Abd-Alrazaq; Eiman Al-Jafar; Mohannad Alajlani; Carla Toro; Dari Alhuwail; Arfan Ahmed; Shuja Mohd Reagu; Najeeb Al-Shorbaji; Mowafa Househ
Journal:  JMIR Serious Games       Date:  2022-01-14       Impact factor: 4.143

Review 6.  The Effectiveness of Serious Games in Alleviating Anxiety: Systematic Review and Meta-analysis.

Authors:  Alaa Abd-Alrazaq; Mohannad Alajlani; Dari Alhuwail; Jens Schneider; Laila Akhu-Zaheya; Arfan Ahmed; Mowafa Househ
Journal:  JMIR Serious Games       Date:  2022-02-14       Impact factor: 3.364

7.  Comparison of behavioural activation with guided self-help for treatment of depression in adults with intellectual disabilities: a randomised controlled trial.

Authors:  Andrew Jahoda; Richard Hastings; Chris Hatton; Sally-Ann Cooper; Dave Dagnan; Ruiqi Zhang; Alex McConnachie; Nicola McMeekin; Kim Appleton; Rob Jones; Katie Scott; Lauren Fulton; Rosie Knight; Dawn Knowles; Chris Williams; Andrew Briggs; Ken MacMahon; Helen Lynn; Ian Smith; Gail Thomas; Craig Melville
Journal:  Lancet Psychiatry       Date:  2017-11-16       Impact factor: 27.083

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.